相关实验视频

Updated: Jul 22, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

针对点击衍生异酸-二氧化碳-1,2,3-三醇的抗菌,抗菌膜,对接,DFT和分子动力学研究

Aman Kumar1, Kashmiri Lal1, Mohd Murtaza2

  • 1Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India.

Journal of biomolecular structure & dynamics
|September 11, 2023
PubMed
概括

合成了新型的伊萨-提奥西米卡巴-1,2,3-二醇混合物,显示出强大的抗微生物和抗菌膜活性. 化合物8d对大肠杆菌和黄金杆菌具有显著的疗效,突出了它们作为新治疗剂的潜力.

关键词:
1,2,3-三醇是什么 1,2,3-三醇是什么异氨酸 是一种异氨酸.抗菌膜活动的抗菌膜活性.抗微生物活性的抗微生物活性.分子对接的分子对接.分子动力学分子动力学

更多相关视频

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.8K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K

相关概念视频

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...